Ads

You May Also Like

Endocyte Reports First Quarter 2016 Financial Results

- Data from Phase 1 Dose Escalation Studies of EC1456 and EC1169 to be Presented ...

Helix BioPharma Corp. Board Changes

RICHMOND HILL, Ontario, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) ...

Sandoz proposed biosimilar pegfilgrastim accepted by EMA for regulatory review

Comprehensive data package demonstrates that Sandoz biosimilar pegfilgrastim matches the reference biologic in terms ...